ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,522,827, issued on Jan. 13, was assigned to The Board of Trustees of the Leland Stanford Junior University (Stanford, Calif.).
"Pan-genotypic agents against influenza virus and methods of using the same" was invented by Jeffrey S. Glenn (Palo Alto, Calif.), Rachel Hagey Saluti (Stanford, Calif.) and Edward A. Pham (Palo Alto, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Methods of inhibiting a respiratory virus, (i.e., a virus associated with a respiratory condition, e.g., influenza A, influenza B, RSV, etc.) in a sample are provided. Aspects of the methods include contacting a sample comprising viral RNA (vRNA) having a target motif with an ef...